Genompic™

The Precision Cancer Support Formula

Genompic™ is an advanced precision oncology support solution designed for confirmed cancer cases where a deeper, molecular-level strategy is required.

Every cancer behaves differently. Even when two patients are diagnosed with the same type of cancer, their underlying molecular activity, gene-expression pattern, tumour behaviour, and treatment response may be very different.

Genompic™ is developed around this principle. Instead of using a general approach, it focuses on identifying selected overactive molecular signals within the patient’s own cancer profile and supporting the regulation of specific gene-expression pathways associated with cancer progression.

This makes Genompic™ a highly personalized molecular support option for patients who require a more targeted, data-driven oncology plan.

WHAT GENOMPIC™ IS?

Genompic™ is a personalized RNA-guided molecular regulation platform.

It is designed to support the modulation of selected overexpressed messenger RNA signals. Messenger RNA, or mRNA, acts like an instruction message inside the body. It tells cells which proteins to produce.

In cancer biology, some of these molecular instructions may become overactive. This may lead to the excessive production of proteins that support abnormal cell survival, growth, communication, resistance, or progression.

Genompic™ is designed to identify and target selected overactive molecular instructions so that the body’s gene-expression activity can be guided toward a more regulated state.

Genompic™ helps quiet down selected overactive cancer-related molecular signals.

HOW GENOMPIC™ WORKS?

The process begins with a patient-specific biological assessment. Through blood-based cancer-cell and molecular profiling, the patient’s cancer-related gene-expression activity is reviewed.

From this profile, selected overexpressed molecular signals are identified. These are the signals that may be contributing to abnormal cancer-cell behaviour.

A personalized RNA-guided formulation is then prepared to focus on the most relevant selected target.

Once administered under professional supervision, the formulation is designed to interact with the selected messenger RNA signal and support the reduction of abnormal protein-signalling activity.

This approach works at the molecular instruction level.

Instead of only asking:

“What type of cancer does the patient have?”

Genompic™ goes deeper and asks:

“Which molecular signal is driving the activity in this individual patient?”

WHAT MAKES GENOMPIC™ DIFFERENT?

• Personalized to Each Patient
  • Genompic™ is not a standard formula. It is developed based on the patient’s own cancer-related biological profile.
• Molecularly Targeted
  • It focuses on selected overexpressed gene signals rather than applying a broad, generalized approach.
• RNA-Guided Technology
  • It uses an RNA-guided regulatory concept inspired by natural gene-expression control pathways.
• Designed for Precision Oncology
  • It supports a more individualized oncology strategy by helping identify and regulate specific molecular activity.
• Supports Doctor-Led Planning
  • Genompic™ is intended to be used as part of a professional oncology support plan, not as a standalone decision or self-directed product.

KEY BENEFITS

• Supports Molecular-Level Precision
  • Helps guide oncology support based on selected gene-expression signals.
• Targets Overactive Cancer-Related Pathways
  • Focuses on molecular signals that may be associated with abnormal cancer-cell activity.
• Personalizes the Support Strategy
  • Allows the approach to be tailored according to the patient’s own cancer-cell profile.
• Supports Treatment Planning Discussions
  • Provides additional molecular insight that may help doctors evaluate suitable next steps.
• Complements Advanced Oncology Monitoring
  • Can be considered alongside other professional oncology assessments and ongoing patient monitoring.

WHO GENOMPIC™ IS DESIGNED FOR?

Genompic™ is designed for confirmed cancer patients who require a personalized molecular support strategy.

It may be considered for patients who:

1. have confirmed cancer diagnosis
2. require deeper molecular insight
3. are exploring precision oncology support
4. need cancer-cell profiling before planning
5. are undergoing doctor-led cancer management
6. require a personalized supportive approach beyond general wellness care

Suitability depends on professional review of:

1. cancer type
2. tumour burden
3. current treatment status
4. blood-based cancer-cell findings
5. imaging results
6. medical history
7. organ function
8. overall clinical condition

IMPORTANT NOTICE

Genompic™ is intended for professional and doctor-supervised use only. It is not intended to diagnose, treat, cure, or prevent any disease as a standalone product. Suitability must be determined by qualified medical professionals based on the patient’s clinical condition, cancer profile, investigation results, and overall treatment plan.